The approval of the mpox vaccine marks a crucial step in combating the disease, especially amidst the current outbreaks in Africa and future potential crises.
WHO Director-General Tedros Adhanom Ghebreyesus emphasized the need for urgent scaling up of procurement and distribution of the vaccine to effectively combat mpox.
Despite the vaccine being effective in adults during the previous outbreak, there remains limited evidence regarding its safety and efficacy in children.
In Congo, nearly 70% of mpox cases involve children under 15, underscoring the urgent need for widespread vaccination efforts among younger populations.
Collection
[
|
...
]